274 related articles for article (PubMed ID: 7556948)
1. Hyperglycemia and diabetic kidney disease. The case for transforming growth factor-beta as a key mediator.
Sharma K; Ziyadeh FN
Diabetes; 1995 Oct; 44(10):1139-46. PubMed ID: 7556948
[TBL] [Abstract][Full Text] [Related]
2. Role of transforming growth factor beta in diabetic nephropathy.
Ziyadeh FN
Exp Nephrol; 1994; 2(2):137. PubMed ID: 8082013
[No Abstract] [Full Text] [Related]
3. Neutralization of TGF-beta by anti-TGF-beta antibody attenuates kidney hypertrophy and the enhanced extracellular matrix gene expression in STZ-induced diabetic mice.
Sharma K; Jin Y; Guo J; Ziyadeh FN
Diabetes; 1996 Apr; 45(4):522-30. PubMed ID: 8603776
[TBL] [Abstract][Full Text] [Related]
4. Renal hypertrophy is associated with upregulation of TGF-beta 1 gene expression in diabetic BB rat and NOD mouse.
Sharma K; Ziyadeh FN
Am J Physiol; 1994 Dec; 267(6 Pt 2):F1094-01. PubMed ID: 7810696
[TBL] [Abstract][Full Text] [Related]
5. Smad pathway is activated in the diabetic mouse kidney and Smad3 mediates TGF-beta-induced fibronectin in mesangial cells.
Isono M; Chen S; Hong SW; Iglesias-de la Cruz MC; Ziyadeh FN
Biochem Biophys Res Commun; 2002 Sep; 296(5):1356-65. PubMed ID: 12207925
[TBL] [Abstract][Full Text] [Related]
6. The key role of the transforming growth factor-beta system in the pathogenesis of diabetic nephropathy.
Chen S; Hong SW; Iglesias-de la Cruz MC; Isono M; Casaretto A; Ziyadeh FN
Ren Fail; 2001; 23(3-4):471-81. PubMed ID: 11499562
[TBL] [Abstract][Full Text] [Related]
7. Characterization of protein kinase C beta isoform activation on the gene expression of transforming growth factor-beta, extracellular matrix components, and prostanoids in the glomeruli of diabetic rats.
Koya D; Jirousek MR; Lin YW; Ishii H; Kuboki K; King GL
J Clin Invest; 1997 Jul; 100(1):115-26. PubMed ID: 9202063
[TBL] [Abstract][Full Text] [Related]
8. Expression of transforming growth factor-beta and type IV collagen in early streptozotocin-induced diabetes.
Park IS; Kiyomoto H; Abboud SL; Abboud HE
Diabetes; 1997 Mar; 46(3):473-80. PubMed ID: 9032105
[TBL] [Abstract][Full Text] [Related]
9. Suppressions of chronic glomerular injuries and TGF-beta 1 production by HGF in attenuation of murine diabetic nephropathy.
Mizuno S; Nakamura T
Am J Physiol Renal Physiol; 2004 Jan; 286(1):F134-43. PubMed ID: 14519594
[TBL] [Abstract][Full Text] [Related]
10. Regulation of connective tissue growth factor activity in cultured rat mesangial cells and its expression in experimental diabetic glomerulosclerosis.
Riser BL; Denichilo M; Cortes P; Baker C; Grondin JM; Yee J; Narins RG
J Am Soc Nephrol; 2000 Jan; 11(1):25-38. PubMed ID: 10616837
[TBL] [Abstract][Full Text] [Related]
11. Reactive oxygen species mediate high glucose-induced plasminogen activator inhibitor-1 up-regulation in mesangial cells and in diabetic kidney.
Lee EA; Seo JY; Jiang Z; Yu MR; Kwon MK; Ha H; Lee HB
Kidney Int; 2005 May; 67(5):1762-71. PubMed ID: 15840023
[TBL] [Abstract][Full Text] [Related]
12. Potential role of TGF-beta in diabetic nephropathy.
Hoffman BB; Sharma K; Ziyadeh FN
Miner Electrolyte Metab; 1998; 24(2-3):190-6. PubMed ID: 9525704
[TBL] [Abstract][Full Text] [Related]
13. Diabetic nephropathy and transforming growth factor-beta: transforming our view of glomerulosclerosis and fibrosis build-up.
Chen S; Jim B; Ziyadeh FN
Semin Nephrol; 2003 Nov; 23(6):532-43. PubMed ID: 14631561
[TBL] [Abstract][Full Text] [Related]
14. Lovastatin inhibits transforming growth factor-beta1 expression in diabetic rat glomeruli and cultured rat mesangial cells.
Kim SI; Han DC; Lee HB
J Am Soc Nephrol; 2000 Jan; 11(1):80-87. PubMed ID: 10616843
[TBL] [Abstract][Full Text] [Related]
15. Role of glomerular ultrafiltration of growth factors in progressive interstitial fibrosis in diabetic nephropathy.
Wang SN; LaPage J; Hirschberg R
Kidney Int; 2000 Mar; 57(3):1002-14. PubMed ID: 10720953
[TBL] [Abstract][Full Text] [Related]
16. Renal TGF-beta regulation in spontaneously diabetic NOD mice with correlations in mesangial cells.
Pankewycz OG; Guan JX; Bolton WK; Gomez A; Benedict JF
Kidney Int; 1994 Sep; 46(3):748-58. PubMed ID: 7996797
[TBL] [Abstract][Full Text] [Related]
17. Long-term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal antitransforming growth factor-beta antibody in db/db diabetic mice.
Ziyadeh FN; Hoffman BB; Han DC; Iglesias-De La Cruz MC; Hong SW; Isono M; Chen S; McGowan TA; Sharma K
Proc Natl Acad Sci U S A; 2000 Jul; 97(14):8015-20. PubMed ID: 10859350
[TBL] [Abstract][Full Text] [Related]
18. Expression of transforming growth factor-beta 1 during diabetic renal hypertrophy.
Shankland SJ; Scholey JW; Ly H; Thai K
Kidney Int; 1994 Aug; 46(2):430-42. PubMed ID: 7967355
[TBL] [Abstract][Full Text] [Related]
19. Mediators of diabetic renal disease: the case for tgf-Beta as the major mediator.
Ziyadeh FN
J Am Soc Nephrol; 2004 Jan; 15 Suppl 1():S55-7. PubMed ID: 14684674
[TBL] [Abstract][Full Text] [Related]
20. Stimulation of TGF-beta type II receptor by high glucose in mouse mesangial cells and in diabetic kidney.
Isono M; Mogyorósi A; Han DC; Hoffman BB; Ziyadeh FN
Am J Physiol Renal Physiol; 2000 May; 278(5):F830-8. PubMed ID: 10807596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
